Published in AIDS Weekly, May 5th, 1997
The vaccine targets the dental cavity-causing bacteria Streptococcus mutans, which sticks to teeth via an adhesin on its surface called AgI/II (also known as antigen B, P1, SpaP, and PAc). The saliva-binding region (SBR) of AgI/II is therefore an attractive vaccine antigen.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.